US Patent 7183264 N-pyrazole A2A receptor agonists
Patent 7183264 was granted and assigned to Cv Therapeutics on February, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Elfatih O. Elzein0
Jeff Zablocki0
Luiz Belardinelli0
Venkata P. Palle0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+77 characters)
Article
Patent abstract
2-adenosine N-pyrazole compounds having the following formula:
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07183264 N-pyrazole A2A receptor agonists US Patent 7183264 N-pyrazole A2A receptor agonists
Infobox
Patent Number
071832640
Patent Number
71832640
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071832640
Date of Patent
February 27, 2007
0Patent Application Number
106523780
Date Filed
August 29, 2003
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07183264 N-pyrazole A2A receptor agonists
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07183264
Date of patent
February 27, 2007
Patent application number
10652378
Date Filed
August 29, 2003
Patent primary examiner
Find more entities like US Patent 7183264 N-pyrazole A2A receptor agonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
